ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 530,72
0,00%
Dow Jones
39 164,06
0,09%
DAX
18 210,55
0,26%
Brent Oil
85,695
0,33%
Bitcoin
61 508,84
-0,17%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Satsuma Pharmaceuticals Inc (STSA)

  7. Satsuma Pharmaceuticals Inc (STSA) Actualités

STSA

Satsuma Pharmaceuticals (STSA)

Satsuma Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:STSA
DateHeureSourceTitreSymboleSociété
20/06/202319h03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:STSASatsuma Pharmaceuticals Inc
15/06/202314h00GlobeNewswire Inc.Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific MeetingNASDAQ:STSASatsuma Pharmaceuticals Inc
12/06/202323h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
09/06/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202322h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h18Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h17Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h17Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
08/06/202315h13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
11/05/202322h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202315h22Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202314h18Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:STSASatsuma Pharmaceuticals Inc
05/05/202312h10Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:STSASatsuma Pharmaceuticals Inc
28/04/202322h12Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
17/04/202322h03Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:STSASatsuma Pharmaceuticals Inc
17/04/202312h30Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:STSASatsuma Pharmaceuticals Inc
28/03/202322h54Edgar (US Regulatory)Annual Report (10-k)NASDAQ:STSASatsuma Pharmaceuticals Inc
14/02/202319h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:STSASatsuma Pharmaceuticals Inc
01/12/202203h55TipRanksSatsuma Pharmaceuticals (STSA) Receives a Hold from Mizuho SecuritiesNASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202222h46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202221h55Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:STSASatsuma Pharmaceuticals Inc
16/11/202214h05TipRanksJonesTrading downgrades Satsuma Pharmaceuticals (STSA) to a HoldNASDAQ:STSASatsuma Pharmaceuticals Inc
14/11/202215h41TipRanksAnalysts Offer Insights on Healthcare Companies: Satsuma Pharmaceuticals (STSA) and Dyadic International (DYAI)NASDAQ:STSASatsuma Pharmaceuticals Inc
14/11/202215h30TipRanksSatsuma Pharma Feels the Pain As Clinical Trial Results DisappointNASDAQ:STSASatsuma Pharmaceuticals Inc
07/11/202201h15TipRanksMizuho Securities Reaffirms Their Buy Rating on Satsuma Pharmaceuticals (STSA)NASDAQ:STSASatsuma Pharmaceuticals Inc
04/11/202205h15TipRanksSatsuma Pharmaceuticals (STSA) Receives a Buy from Mizuho SecuritiesNASDAQ:STSASatsuma Pharmaceuticals Inc
03/11/202221h43Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:STSASatsuma Pharmaceuticals Inc
01/11/202216h50TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:STSASatsuma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:STSA

Dernières Valeurs Consultées

LSE
ESTS
UNSW
XETHETH
Xplosive Ethereum
BIT
UC8AKR
Unicredit Bank
BIT
XGBU
Xtrackers USD Corporate ...
TG
54GA
Sangoma Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés